Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Jacobsen | M | 65 | 11 years | |
| Tad Heitmann | M | - | 6 years | |
| Marvin J. Garrett | M | 73 | 10 years | |
| Michelle Senchyna | M | - | 4 years | |
| Craig R. Skenes | M | - | 10 years | |
| Gregory Jones | M | - | 4 years | |
| Leon J. Atencia | M | - | 3 years | |
| Carolyn McAuliffe | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Douglas Ingram | M | 61 | 19 years | |
| Richard Rubino | M | 66 | 9 years | |
| Benjamin McGraw | M | 75 |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 11 years |
| Lauren Silvernail | F | 65 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 17 years |
| James Hindman | M | 63 | 31 years | |
| Jeffrey Edwards | M | 64 | 22 years | |
| David Gryska | M | 68 | 8 years | |
| Vicente J. Anido | M | 71 | 12 years | |
| Herb Boyer | M | 87 | 19 years | |
| Geoffrey Duyk | M | 64 | 12 years | |
| David Pyott | M | 70 | 17 years | |
| Aimee Weisner | F | 55 | 4 years | |
| Peter Hutt | M | 89 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 10 years |
| Caroline F. van Hove | F | 43 | 16 years | |
| Peter John McDonnell | M | 66 | 2 years | |
| Michael McCleerey | M | - | 8 years | |
| James V. Mazzo | M | 66 | - | |
| Michael du Toit | M | 71 | 7 years | |
| Amit Bhupendra Shah | M | 57 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 2 years |
| Janet L. Conway | M | 74 | 9 years | |
| David Mack | M | 62 | 8 years | |
| Gary Menichini | M | - | - | |
| Gerald D. Cagle | M | 79 | 9 years | |
| J. Michael Judy | M | - | 8 years | |
| Wayne I. Roe | M | 73 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 4 years |
| Richard Croarkin | M | 69 | 7 years | |
| John W. LaRocca | M | 59 | 4 years | |
| Glenn E. Davis | M | 74 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | - |
| William Humphries | M | 57 | 8 years | |
| Julie McHugh | F | 59 | 7 years | |
| Abhay Joshi | M | 61 | 5 years | |
| Leonard Schaeffer | M | 78 | 18 years | |
| Richard Williams | M | 80 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 10 years |
| Louis T. Rosso | M | - | 16 years | |
| Kathleen McGinley | F | 74 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 17 years |
| Rajkumar Kannan | M | 61 | 1 years | |
| Kirk McMullin | M | 70 |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 7 years |
| Christopher Staten | M | - | 6 years | |
| Michael R. Gallagher | M | 77 | - | |
| Eric Brandt | M | 62 | 6 years | |
| Les Kaplan | M | 73 | 21 years | |
| Dennis J. Henner | M | 72 | 4 years | |
| Murray Goldberg | M | 79 | 7 years | |
| Deanne F. Melloy | F | - | - | |
| Julian Gangolli | M | 66 | 17 years | |
| Robert T. Joseph | M | 47 | 2 years | |
| Nina Ohara | M | - | 2 years | |
| Amine Sinmazisik | F | - | - | |
| Isabel Moredo | F | - | - | |
| Robert Finan | M | - | - | |
| Catherine Turkel | M | 63 | 17 years | |
| Charlene E. Davis | F | - | - | |
| David Hollander | M | 50 | 3 years | |
| Chris Dax | M | - |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | 2 years |
| Tori Arens | F | - | 4 years | |
| Shaun Gentry | M | - | - | |
| Erin Horn | M | - | - | |
| Carmen Wasserman | M | - | - | |
| Ami Bavishi | M | - | - | |
| Nils Hauptmann | M | - | - | |
| Judith Robertson | F | 64 | 2 years | |
| F. Ball | M | 68 | 16 years | |
| Lisa D. Parr | M | 59 | 3 years | |
| Dennis Podlesak | M | 66 | 4 years | |
| George Lasezkay | M | 72 | 13 years | |
| Albert Moyer | M | 80 | 3 years | |
| Jacqueline J. Schiavo | F | 75 | 25 years | |
| James F. Barlow | M | 65 | 13 years | |
| Brian Levy | M | 72 | 3 years | |
| Scott Michael Whitcup | M | 64 | 15 years | |
| Raymond Diradoorian | M | 66 | 34 years | |
| Robert C. Bishop | M | 81 | 6 years | |
| Karen Osar | F | 74 | 7 years | |
| A. Bender | M | 84 | 25 years | |
| C. Trenary | M | 66 | 8 years | |
| Donald M. Earhart | M | 79 | 4 years | |
| Edward P. Monaghan | M | - | - | |
| Tsutomu Okimura | M | - | - | |
| Patrick O'Brien | M | - | 2 years | |
| Steven R. Carlson | M | 67 | 8 years | |
| James R. Largent | M | 74 | 6 years | |
| Handel E. Evans | M | - | 18 years | |
| Susan H. Caballa | F | 79 | 4 years | |
| Niv Edward Caviar | M | 56 | 5 years | |
| David F. Power | M | - | 18 years | |
| Rosh Chandraratna | M | 75 | 20 years | |
| David Endicott | M | 58 | 27 years | |
| John Gainor | M | - | 5 years | |
| Michael Rowe | M | 62 | 2 years | |
| Larry M. Counen | M | - | 12 years | |
| Luis G. Vargas | M | - | 2 years | |
| Brian Sakurada | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas A. Mitro
- Personal Network
